ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that multiple abstracts ...

A foundational guide for stage 2 prostate cancer clarifies staging implications, localized-disease management, and trade-offs among surgery, radiation, and quality-of-life outcomes to support informed ...

The Lehigh Valley Auto Show showcases innovation, creativity, and automotive excellence, drawing car enthusiasts from across the region. This year, it will also put men’s health in the spotlight with ...

Healthcare provider, LivingCare Group has been selected as the proposed imaging partner for the IMProVE clinical trial, a prostate cancer early-detection programme funded by Yorkshire Cancer Research.

A 1951 CIA report on parasites and tumors spread online in March 2026 — but it was declassified years ago and does not reveal a cancer cure.

Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026 ...

Prostate-specific membrane androgen PET/CT can help clinicians intensify or de-escalate care for men with prostate cancer who have biochemical recurrence following radical prostatectomy.A ...

A North Carolina man’s life‑changing prostate cancer diagnosis is opening doors to conversations on men’s health.

White House chief of staff Susie Wiles has been diagnosed with early stage breast cancer, President Donald Trump announced Monday.

Early-stage prostate cancer rarely causes symptoms, making routine screening the most reliable way to catch it before it ...

Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing mortality and avoiding unnecessary harms, says new research.

Prostate cancer screening compares favorably to screening for breast cancer in identifying significant cancers, reducing ...